Showing results (1581-1590 of 1,868) with videos related to

Sort By:
Pageof 187
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 9, 2023
Investigation of an international water polo tournament in Czechia as a potential source for early introduction of the SARS-CoV-2 Omicron variant into Belgium, Switzerland and Germany, November 2021Christoph Rudin, Nena Bollen, Samuel L Hong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2022
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLCMarina K Baine, Christopher A Febres-Aldana, Jason C Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung CancerKen Suzawa, Michael Offin, Daniel Lu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 30, 2019
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indicesNatasha Rekhtman, Patrice Desmeules, Anna M Litvak, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2015
Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniaeAsma Khatri, Nina Naeger Murphy, Peter Wiest, et al.
Genes|November 3, 2020
Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European PopulationsAnca Liliana Cismaru, Deborah Rudin, Luisa Ibañez, et al.
ESC Heart Failure|December 22, 2020
Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre studyPeter Jirak, Robert Larbig, Zornitsa Shomanova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2019
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical OutcomesMichael Offin, Joseph M Chan, Megan Tenet, et al.
Pageof 187